In ACPA+ RA patients with the DRB1*04 or *10 alleles, we did not find any statistically significant variations in hematological and biochemical markers. Our findings indicate that the ACPA-positive status, hematological and biochemical markers, and the existence of the risk genes under investigation are unrelated. This evidence concerns the gene PRTN3 and rheumatoid arthritis.